Memantin
Medikament
Memantin ist ein Derivat des Amantadins und wird zur Behandlung von moderaten bis schweren Demenz-Formen vom Alzheimer-Typ eingesetzt. Es ist der einzige Vertreter der Klasse der NMDA-Rezeptor-Antagonisten bei den Anti-Alzheimer-Medikamenten.... Wikipedia
CAS-Nummer: 19982-08-2 (Memantin); 41100-52-1 (Memantin·Hydrochlorid)
EG-Nummer (Listennummer): 690-724-9
Weitere Fragen
Was bewirkt das Medikament Namenda?
Ist Namenda ein Beruhigungsmittel?
Was ist der Unterschied zwischen Aricept und Namenda?
Wie lange dauert es, bis Namenda wirkt?
Namenda is used to treat moderate to severe dementia of the Alzheimer's type. Namenda's mechanism of action is to help balance a brain chemical called glutamate ...
27.06.2024 · Memantine is commonly used to treat moderate to severe dementia related to Alzheimer's disease. Memantine may also be used for other conditions ...
Andere suchen auch nach
NAMENDA (memantine hydrochloride) is indicated for the treatment of moderate to severe dementia of the Alzheimer's type. 2. DOSAGE AND ADMINISTRATION. The ...
15.04.2016 · Memantine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, ...
Memantine is a medication that comes in a tablet form. It treats dementia caused by Alzheimer's disease. Dementia affects your thinking, memory, reasoning, ...
NAMENDA (memantine hydrochloride) is indicated for the treatment of moderate to severe dementia of the Alzheimer's type. 2. DOSAGE AND ADMINISTRATION. The ...
01.02.2024 · Memantine is used to treat moderate to severe Alzheimer's disease. Memantine is not a cure for Alzheimer's disease but it can help people with the disease.
17.04.2024 · Namenda helps improve memory and thinking. It reduces the symptoms of Alzheimer's dementia, which can make it easier to do everyday activities.
Namenda ... A drug used to treat dementia caused by Alzheimer disease. It is also being studied in the treatment of side effects from whole-brain radiation ...
Treatment of moderate-to-severe dementia. Tablet: 5 mg PO once daily initially; increased by increments of 5 mg/day each week; maintenance target dosage (>5 ...